San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, CloudCath is raising $12 Million in new funding. Sources indicate as part of senior management Chief Executive Officer, Aly ElBadry played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CloudCath

Founded in 2017, CloudCath is a digital health medical device company that is dedicated to remote complication monitoring for patients undergoing catheter-based treatments. Its remote monitoring platform analyzes drainage fluid, utilizing proprietary data analysis algorithms to detect fluid property deviations, and automatically transmits notifications to healthcare providers, enabling earlier intervention in cases of catheter-associated complications like infection. CloudCath’s first product is designed for patients undergoing peritoneal dialysis.

CloudCath is a proud member of the StartX Med Summer 2018 Cohort, a showcase company in the MedTech Innovator Summer 2019 cohort & recipient of UCSF’s Rosenman Innovator award in 2018.

The company is headquartered in San Francisco and backed by leading investors in both healthcare and technology.

To learn more about CloudCath, visit http://www.cloudcath.com/

Contact:
Aly ElBadry, Chief Executive Officer
650-308-6699
https://www.linkedin.com/in/aly-el-badry-a8807044/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved